Neck dissection can be avoided after sequential chemoradiotherapy and negative post-treatment positron emission tomography-computed tomography in N2 Head and neck squamous cell carcinoma

Clinical Oncology

Volumn 23, Issue 8, 2011, Pages 512-517

  Loo, S W ^a   Geropantas, K ^a   Beadsmoore, C ^a   Montgomery, P Q ^a   Martin, W M C ^a   Roques, T W ^a  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Head and neck squamous cell carcinoma; Neck dissection; PET CT; Sequential chemoradiotherapy

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER INHIBITION; CANCER RECURRENCE; CANCER STAGING; CERVICAL LYMPHADENOPATHY; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISTANT METASTASIS; FALSE POSITIVE RESULT; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; MULTIPLE CYCLE TREATMENT; NECK DISSECTION; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SURVIVAL RATE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 80052282829     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2011.03.008     Document Type: Article

References (32)

1. Calais G., Alfonsi M., Bardet E., et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 1999, 91:2081-2086.
2. Pignon J.P., Bourhis J., Domenge C., Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet 2000, 355:949-955.
3. Adelstein D.J., Li Y., Adams G.L., et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003, 21:92-98.
4. Stenson K.M., Haraf D.J., Pelzer H., et al. The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissection. Arch Otolaryngol Head Neck Surg 2000, 126:950-956.
5. McHam S.A., Adelstein D.J., Rybicki L.A., et al. Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer?. Head Neck 2003, 25:791-798.
6. Lavertu P., Adelstein D.J., Saxton J.P., et al. Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer. Head Neck 1997, 19:559-566.
7. Brizel D.M., Prosnitz R.G., Hunter S., et al. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004, 58:1418-1423.
8. Grabenbauer G.G., Rodel C., Ernst-Stecken A., et al. Neck dissection following radiochemotherapy of advanced head and neck cancer - for selected cases only?. Radiother Oncol 2003, 66:57-63.
9. Argiris A., Stenson K.M., Brockstein B.E., et al. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck 2004, 26:447-455.
10. Davidson B.J., Newkirk K.A., Harter K.W., Picken C.A., Cullen K.J., Sessions R.B. Complications from planned, posttreatment neck dissections. Arch Otolaryngol Head Neck Surg 1999, 125:401-405.
11. Pellitteri P.K., Ferlito A., Rinaldo A., et al. Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: is it necessary for all?. Head Neck 2006, 28:166-175.
12. Peters L.J., Weber R.S., Morrison W.H., Byers R.M., Garden A.S., Goepfert H. Neck surgery in patients with primary oropharyngeal cancer treated by radiotherapy. Head Neck 1996, 18:552-559.
13. Johnson C.R., Silverman L.N., Clay L.B., Schmidt-Ullrich R. Radiotherapeutic management of bulky cervical lymphadenopathy in squamous cell carcinoma of the head and neck: is postradiotherapy neck dissection necessary?. Radiat Oncol Investig 1998, 6:52-57.
14. Corry J., Peters L., Fisher R., et al. N2-N3 neck nodal control without planned neck dissection for clinical/radiologic complete responders - results of Trans Tasman Radiation Oncology Group Study 98.02. Head Neck 2008, 30:737-742.
15. Yao M., Luo P., Hoffman H.T., et al. Pathology and FDG PET correlation of residual lymph nodes in head and neck cancer after radiation treatment. Am J Clin Oncol 2007, 30:264-270.
16. Posner M.R. Paradigm shift in the treatment of head and neck cancer: the role of neoadjuvant chemotherapy. Oncologist 2005, 10(Suppl. 3):11-19.
17. Gibson M.K., Forastiere A.A. Reassessment of the role of induction chemotherapy for head and neck cancer. Lancet Oncol 2006, 7:565-574.
18. Robbins K.T., Atkinson J.L., Byers R.M., et al. The use and misuse of neck dissection for head and neck cancer. J Am Coll Surg 2001, 193:91-102.
19. Goguen L.A., Posner M.R., Tishler R.B., et al. Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 2006, 134:916-922.
20. Freeman D.E., Mancuso A.A., Parsons J.T., et al. Irradiation alone for supraglottic larynx carcinoma: can CT findings predict treatment results?. Int J Radiat Oncol Biol Phys 1990, 19:485-490.
21. Lee W.R., Mancuso A.A., Saleh E.M., et al. Can pretreatment computed tomography findings predict local control in T3 squamous cell carcinoma of the glottic larynx treated with radiotherapy alone?. Int J Radiat Oncol Biol Phys 1993, 25:683-687.
22. Posner M.R., Hershock D.M., Blajman C.R., et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 2007, 357:1705-1715.
23. Vermorken J.B., Remenar E., van Herpen C., et al. Cisplatin, fluorouracil and docetaxel in unresectable head and neck cancer. N Engl J Med 2007, 357:1695-1704.
24. Paccagnella A., Ghi M.G., Loreggian L., et al. Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study. Ann Oncol 2010, 21:1515-1522.
25. Yao M., Graham M.M., Hoffman H.T., et al. The role of post-radiation therapy FDG PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2004, 59:1001-1010.
26. Yao M., Smith R.B., Graham M.M., et al. The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment. Int J Radiat Oncol Biol Phys 2005, 63:991-999.
27. Porceddu S.V., Jarmolowski E., Hicks R.J., et al. Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer. Head Neck 2005, 27:175-181.
28. Ong S.C., Schoder H., Lee N.Y., et al. Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for locoregional advanced head and neck cancer. J Nucl Med 2008, 49:532-540.
29. Cho A.H., Shah S., Ampil F., Bhartur S., Nathan C.O. N2 disease in patients with head and neck squamous cell cancer treated with chemoradiotherapy. Is there a role for posttreatment neck dissection?. Arch Otolaryngol Head Neck Surg 2009, 135:1112-1118.
30. Brkovich V.S., Miller F.R., Karnad A.B., Hussey D.H., McGuff H.S., Otto R.A. The role of positron emission tomography scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy. Laryngoscope 2006, 116:855-858.
31. Teknos T.N., Rosenthal E.L., Lee D., Taylor R., Marn C.S. Positron emission tomography in the evaluation of stage III and IV head and neck cancer. Head Neck 2001, 23:1056-1060.
32. Schwartz D.L., Rajendran J., Yueh B., et al. Staging of head and neck squamous cell cancer with extended-field FDG-PET. Arch Otolaryngol Head Neck Surg 2003, 129:1173-1178.